To determine the potential effects of exendin 2029 on GLP-1R and glucose regulation, we performed an acute IPGTT in 8-week-old mice
Jin X, Beguerie JR, Zhang W, et al
GLP-1 receptor activation The GLP-1 component of retatrutide reduces appetite through multiple mechanisms: slowing gastric emptying (food stays in your stomach longer, so you feel full sooner), signaling satiety centers in the brain (your brain gets a stronger "stop eating" signal), and enhancing insulin secretion in response to meals
Double knockout animals for both GIPR and GLP-1R (DIRKO) showed in cortical bone the same bone alterations seen in single GLP-1R KO animals [45]
On its own, glucagon usually raises blood sugar
The drug also causes food to linger in the stomach, which prolongs the feeling of fullness